Formulary Drug Reviews: Plecanatide. - Wikidata - wikimedia - TriplyDB

Formulary Drug Reviews: Plecanatide.

Formulary Drug Reviews: Plecanatide.

http://www.wikidata.org/entity/Q49587169

about

Formulary Drug Reviews: Plecanatide.

http://www.wikidata.org/entity/Q49587169

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Formulary Drug Reviews: Plecanatide.

@en

Formulary Drug Reviews: Plecanatide.

@nl

type

label

Formulary Drug Reviews: Plecanatide.

@en

Formulary Drug Reviews: Plecanatide.

@nl

prefLabel

Formulary Drug Reviews: Plecanatide.

@en

Formulary Drug Reviews: Plecanatide.

@nl

P1433

Q49587169-6D4673C1-47BE-46C7-A95A-E7156F6E69E4

P1476

Q49587169-1CB9A4B9-75CA-4672-BA77-D744F605E114

P2093

Q49587169-0F044FA4-0FCD-4599-B339-1A0A9B803986

P2860

Q49587169-22CAC9FC-B92C-4776-9356-79DDBBB31C52

Q49587169-2E27A539-8C2D-4405-8058-EEB80941B21C

Q49587169-40FBF97C-8621-42F2-8544-B88DCC0CC566

Q49587169-4E58A3D5-E864-42C0-9107-D5992BA38201

Q49587169-780945A9-795B-4768-A545-95E073271C10

Q49587169-906F42CD-E745-4151-84A0-A5E559FEE8ED

Q49587169-D44DA0E1-B01B-48E8-8E74-7D718F0B163D

Q49587169-DCF73BC3-11A6-47EE-9270-AAD4176F6F79

P304

Q49587169-E26521BF-AB46-4C6D-A4A4-7ABFF4ACBB94

P31

Q49587169-74674188-6F16-4FC2-BEB5-D5A1C096E8FC

P356

Q49587169-424204F9-56DD-4D65-B0D3-3B1A8F363167

P433

Q49587169-989FF408-C40B-4ADA-B74D-B1FE09D1943B

P478

Q49587169-C3C79BA4-F982-4DB6-9E00-6FFEF0992381

P577

Q49587169-8DEC7B0B-CC0D-4483-9771-E98D24BAB336

P698

Q49587169-58E6C68D-7848-433C-B121-463CED2A9C6E

P932

Q49587169-E629FC99-8C36-495D-9C45-6D713DD35C1C

P356

0018578717717623

P1433

Hospital pharmacy

P1476

Formulary Drug Reviews: Plecanatide.

@en

P2093

Danial E Baker

http://www.w3.org/2001/XMLSchema#string

P2860

Constipation-predominant irritable bowel syndrome: a review of current and emerging drug therapies.

Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis.

Pharmacology and clinical potential of guanylyl cyclase C agonists in the treatment of ulcerative colitis.

Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.

American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation.

Emerging treatments in Neurogastroenterology: Perspectives of guanylyl cyclase C agonists use in functional gastrointestinal disorders and inflammatory bowel diseases.

Clarification of linaclotide pharmacology presented in a recent clinical study of plecanatide.

Plecanatide, an oral guanylate cyclase C agonist acting locally in the gastrointestinal tract, is safe and well-tolerated in single doses.

P304

400-405

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0018578717717623

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29276262

http://www.w3.org/2001/XMLSchema#string

P932

5735701

http://www.w3.org/2001/XMLSchema#string